Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

YM BioSciences starts phase II trial of CYT-387 in myelofibrosis

Sep. 30, 2011

Onyx Pharmaceuticals completes carfilzomib NDA submission

Sep. 29, 2011

Cell Therapeutics completes assessment required for pixantrone NDA

Sep. 29, 2011

FDA accepts Talon Therapeutics' Marqibo NDA for filing

Sep. 29, 2011

Enrollment completed in Rexahn Pharmaceuticals' phase II Archexin trial

Sep. 29, 2011

Novel protein kinase inhibitors for cancer claimed by OSI

Sep. 29, 2011

Treatment begins in phase III PI-88 study

Sep. 29, 2011

Sunesis begins phase I trial of MLN-2480

Sep. 29, 2011

Riemser Arzneimittel receives German license for CINV combination therapy

Sep. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...